Found: 91
Select item for more details and to access through your institution.
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304552
- By:
- Publication type:
- Article
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 6, p. 245, doi. 10.3201/eid3002.230863
- By:
- Publication type:
- Article
Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00616-5
- By:
- Publication type:
- Article
Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 4, p. 1158, doi. 10.1093/infdis/jiad550
- By:
- Publication type:
- Article
Reply to Niu and Drain.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 802, doi. 10.1093/cid/ciad486
- By:
- Publication type:
- Article
Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States.
- Published in:
- Journal of the International AIDS Society, 2024, v. 27, n. 3, p. 1, doi. 10.1002/jia2.26223
- By:
- Publication type:
- Article
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 2, p. 245, doi. 10.3201/eid3002.230863
- By:
- Publication type:
- Article
Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy.
- Published in:
- Frontiers in Reproductive Health, 2023, v. 5, p. 1, doi. 10.3389/frph.2023.1224580
- By:
- Publication type:
- Article
Refitting Estimated Glomerular Filtration Rate Equations to Find A FIT FOR ALL.
- Published in:
- Clinical Laboratory News, 2023, p. 18
- By:
- Publication type:
- Article
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care.
- Published in:
- Journal of Applied Laboratory Medicine, 2023, v. 8, n. 4, p. 789, doi. 10.1093/jalm/jfad022
- By:
- Publication type:
- Article
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 7, p. 1657, doi. 10.1007/s11095-022-03440-6
- By:
- Publication type:
- Article
HIV TESTING RECLASSIFICATION: A STEP TOWARDS EQUITY.
- Published in:
- Clinical Laboratory News, 2023, p. 18
- By:
- Publication type:
- Article
Updating the Adherence–Response for Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Cisgender Women.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1850, doi. 10.1093/cid/ciad021
- By:
- Publication type:
- Article
CABOTEGRAVIR PHARMACOLOGY IN THE BACKGROUND OF DELAYED INJECTIONS IN HPTN 084.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 65
- By:
- Publication type:
- Article
THE LEVI SYNDROME: CHARACTERISTICS OF EARLY HIV INFECTION WITH CABOTEGRAVIR FOR PrEP.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 66
- By:
- Publication type:
- Article
CAB LA FOR HIV PREVENTION IN AFRICAN CISGENDER FEMALE ADOLESCENTS (HPTN 084-01).
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 66
- By:
- Publication type:
- Article
Correlates of self-reported and biomarker based adherence to daily oral HIV pre-exposure prophylaxis among a cohort of predominantly men who have sex with men in Nigeria.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0282999
- By:
- Publication type:
- Article
Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 557, doi. 10.1002/cpt.2801
- By:
- Publication type:
- Article
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
- Published in:
- PLoS Medicine, 2023, v. 19, n. 2, p. 1, doi. 10.1371/journal.pmed.1004088
- By:
- Publication type:
- Article
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2170, doi. 10.1093/infdis/jiac415
- By:
- Publication type:
- Article
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
- Published in:
- AIDS & Behavior, 2022, v. 26, n. 12, p. 4107, doi. 10.1007/s10461-022-03736-z
- By:
- Publication type:
- Article
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0275794
- By:
- Publication type:
- Article
Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4607, doi. 10.1111/bcp.15439
- By:
- Publication type:
- Article
A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4623, doi. 10.1111/bcp.15477
- By:
- Publication type:
- Article
Decreasing the Lower Limit of Quantitation for Urine Albumin Improves Clinical Utility<sup> </sup>.
- Published in:
- Journal of Applied Laboratory Medicine, 2022, v. 7, n. 5, p. 1145, doi. 10.1093/jalm/jfac046
- By:
- Publication type:
- Article
Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 8, p. 3674, doi. 10.1111/bcp.15310
- By:
- Publication type:
- Article
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11020-2
- By:
- Publication type:
- Article
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
- Published in:
- AIDS & Behavior, 2022, v. 26, n. 5, p. 1333, doi. 10.1007/s10461-021-03490-8
- By:
- Publication type:
- Article
Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 4, p. 1667, doi. 10.1111/bcp.14980
- By:
- Publication type:
- Article
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review.
- Published in:
- Clinical Chemistry, 2022, v. 68, n. 4, p. 521, doi. 10.1093/clinchem/hvab279
- By:
- Publication type:
- Article
Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.799501
- By:
- Publication type:
- Article
Extending Drug Release from Implants via Transcutaneous Refilling with Solid Therapeutics.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 2, p. 1, doi. 10.1002/adtp.202100214
- By:
- Publication type:
- Article
Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. 101, doi. 10.1093/cid/ciaa537
- By:
- Publication type:
- Article
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
- Published in:
- Journal of the International AIDS Society, 2021, v. 24, n. 6, p. 1, doi. 10.1002/jia2.25747
- By:
- Publication type:
- Article
Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 3, p. 1, doi. 10.1002/adtp.202000163
- By:
- Publication type:
- Article
Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021).
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 3, p. 1, doi. 10.1002/adtp.202170005
- By:
- Publication type:
- Article
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 3, p. 486, doi. 10.1093/cid/ciaa785
- By:
- Publication type:
- Article
Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11`, p. N.PAG, doi. 10.3389/fphar.2020.569373
- By:
- Publication type:
- Article
Nimodipine improves cortical efficiency during working memory in healthy subjects.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41398-020-01066-z
- By:
- Publication type:
- Article
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial.
- Published in:
- Journal of the International AIDS Society, 2020, v. 23, n. 11, p. 1, doi. 10.1002/jia2.25634
- By:
- Publication type:
- Article
Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240890
- By:
- Publication type:
- Article
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 10, p. 981, doi. 10.3390/pharmaceutics12100981
- By:
- Publication type:
- Article
Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.
- Published in:
- AIDS & Behavior, 2020, v. 24, n. 7, p. 2082, doi. 10.1007/s10461-019-02773-5
- By:
- Publication type:
- Article
Transgender women on oral HIV pre‐exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men.
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 11, p. N.PAG, doi. 10.1002/jia2.25405
- By:
- Publication type:
- Article
Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical Trial.
- Published in:
- AIDS & Behavior, 2019, v. 23, n. 9, p. 2337, doi. 10.1007/s10461-019-02592-8
- By:
- Publication type:
- Article
Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0217229
- By:
- Publication type:
- Article